4/A
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0000899243-18-000527
Chief Scientific Officer gave up 9,558 shares (to pay taxes)
- Chief Scientific Officer acquired 18,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Erlander Mark · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-01-02 | Exercise or conversion : show line 1 in the form | +18,750 | 66,855 | D |
| 2018-01-02 | Shares withheld for taxes : show line 2 in the form | −9,558 | 57,297 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-01-02 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −18,750 | 146,250 | D |
Loading xslF345X03/doc4a.xml…